videoSlug

VideoSlug_VideoQuery

slug

VideoPageContentQuery

content

videos

query VideoSlug_VideoQuery(
  $videoSlug: String!
) {
  ...VideoPageContentQuery_1X4EH4
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment LatestVideos_Videos on Query {
  videos(first: 5, upcoming: false, order: {field: liveTime, direction: DESC}) {
    edges {
      node {
        id
        title
        lang
        pageUrl
        liveTime
        isLive
        companies {
          name
          squareLogoUrl
          id
        }
      }
    }
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment VideoPageContentQuery_1X4EH4 on Query {
  content(slug: $videoSlug, type: [VIDEO, WEBCAST]) {
    __typename
    id
    title
    slug
    lang
    htmlBody
    isPremium
    companies {
      viewerIsFollowing
      id
      name
      pageUrl
      defaultInstrument {
        id
        isin
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    createdAt
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    ... on Video {
      imgUrl
      videoEmbedUrl(location: "inderes")
      audioEmbedUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ... on Webcast {
      imgUrl
      videoEmbedUrl(location: "inderes")
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
  }
  ...LatestVideos_Videos
}


type

__typename

title

lang

htmlBody

isPremium

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

first

order

upcoming

edges

Head of Equities

Michael Friis

ExpreS2ion Biotech Holding

ExpreS2ion Biotechnologies is carrying out a rights issue with preferential rights for existing shareholders, amounting to approximately SEK 60 million. The company published its prospectus the 5 June 2024.

CEO Bent U. Frandsen and CFO Keith Alexander will join us on 14 June at 11.00 and take a deeper dive into details of the rights issue and warrant programs, timetable, rationale for the capital raise, and use of proceeds.

You can already now sign up for the event and send in your questions. You don&#x2019;t have to participate live to send in questions for the event.
ExpreS2ion Biotechnologies is carrying out a rights issue with preferential rights for existing shareholders, amounting to approximately SEK 60 million. The company published its prospectus the 5 June 2024. CEO Bent U. Frandsen and CFO Keith Alexander will join us on 14 June at 11.00 and take a deeper dive into details of the rights issue and warrant programs, timetable, rationale for the capital raise, and use of proceeds. ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines through the use of its non-viral Drosophila S2 cells-based expression system. Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis, 14.16, 7 June 2024.

HC Andersen Capital

ExpreS2ion Biotechnologies – Rights Issue 2024

United Bankers

Robit

Endomines Finland

Orthex

Enersense International

Outokumpu

Multitude

Sonae

Investor Day | Nov. 24, 2025

Novo Nordisk

Ørsted

NNIT

Trifork Group

cBrain

Pandora

Vestas Wind Systems

Rovsing

HCA Morgenbørs 23/12 - Flade futures og fokus på Novo Nordisk og Ørsted

GomSpace Group

ALK-Abelló

Torm

Roblon

Scandinavian Medical Solutions

Lån og Spar Bank

SKAKO

HCA Morgenbørs 22/12 - Positiv stemning i Asien og amerikanske futures i plus, mens Europa er fladt

Aquaporin

GreenMobility

Matas

SP Group

Genmab

HCA Morgenbørs 19/12 - Små fald i den europæiske åbning og fokus på flere danske aktier

Talenom

Talenom - Planned demerger and strategies of Talenom and Easor

Seneste videoer